沉默SF3B1促进人肺癌细胞系A549凋亡并抑制其增殖及侵袭

doi:10.16352/j.issn.1001-6325.2023.08.1265

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (8): 1265-1270.doi: 10.16352/j.issn.1001-6325.2023.08.1265

沉默SF3B1促进人肺癌细胞系A549凋亡并抑制其增殖及侵袭

张小婉¹, 康霞², 姚小英³, 谢芳¹, 李莹^1*

1.中国人民解放军西部战区总医院老年医学科,四川成都 610083;
2.金堂县第一人民医院肿瘤科,四川成都 610400;
3.中国人民解放军西部战区总医院超声科,四川成都 610083

收稿日期:2022-08-09 修回日期:2023-04-10 出版日期:2023-08-05 发布日期:2023-07-26
通讯作者: ^*liying1721@126.com

Silencing SF3B1 promotes apoptosis and inhibits proliferation and invasion of human lung cancer cell line A549

ZHANG Xiaowan¹, KANG Xia², YAO Xiaoying³, XIE Fang¹, LI Ying^1*

1. Department of Geriatrics, the General Hospital of Western Theater Command PLA, Chengdu 610083;
2. Department of Oncology, Jintang First People's Hospital, Chengdu 610400;
3. Department of Ultrasound, the General Hospital of Western Theater Command PLA, Chengdu 610083

Received:2022-08-09 Revised:2023-04-10 Online:2023-08-05 Published:2023-07-26
Contact: ^*liying1721@126.com

摘要/Abstract

摘要： 目的探索剪接因子3B亚基(SF3B1)对人肺癌细胞凋亡、增殖及侵袭的影响。方法选择西部战区总医院2017年6月～2020年6月确诊的非小细胞肺癌(NSCLC)患者为研究对象,检测癌组织、癌旁组织SF3B1水平,并分析SF3B1与患者临床病理特征、生存预后的关系。培养A549细胞,并将细胞分为对照组、转染si-NC组和si-SF3B1组,流式细胞术测定细胞凋亡,CCK-8法检测细胞的增殖,Transwell实验检测细胞侵袭能力,Western blot检测Ras/Raf/ERK信号蛋白表达。结果 NSCLC癌组织中SF3B1 mRNA水平显著高于癌旁组织(P＜0.05),A549细胞中SF3B1 mRNA水平显著高于人正常肺上皮细胞(P＜0.05);SF3B1与NSCLC患者淋巴结转移、肿瘤大小及分化程度存在相关性(P＜0.05);SF3B1高表达患者中位总生存期(OS)、无进展生存期(PFS)均明显低于SF3B1低表达患者(P＜0.05);沉默SF3B1后,促进A549细胞凋亡,抑制其增殖、侵袭(P＜0.05);沉默SF3B1显著降低A549细胞Ras、Raf及p-ERK蛋白水平(P＜0.05)。结论 SF3B1在NSCLC高表达,沉默SF3B1可促进肺癌细胞凋亡,抑制细胞增殖、侵袭。

关键词: 非小细胞肺癌, 剪接因子3B亚基, Ras, Raf, ERK

Abstract: Objective To explore the effect of splicing factor 3B subunit (SF3B1) on apoptosis, proliferation and invasion of human lung cancer cells. Methods Non-small cell lung cancer(NSCLC) patients in the General Hospital of Western Theater Command PLA from June 2017 to June 2020 were selected as the research objects to detect the level of SF3B1 in cancer and adjacent tissues, and to analyze the relationship between SF3B1 and the pathological characteristics, survival and prognosis of patients. In addition, A549 cells were cultured and divided into control group, transfected si-NC group and si-SF3B1 group. Cell apoptosis was detected by flow cytometry, cell proliferation was detected by CCK-8, cell invasion was detected by Transwell, and the expression of Ras/Raf/ERK signal protein was detected by Western blot. Results The level of SF3B1 mRNA in cancer tissues was significantly higher than that in adjacent tissues(P＜0.05), and its level in A549 cells was significantly higher than that in normal lung epithelial cell line BEAS-2B(P＜0.05). The high level of SF3B1 was related to lymph node metastasis, tumor size and differentiation(P＜0.05). The median overall survival(OS) and progression free survival(PFS) of patients with low expression of SF3B1 were significantly higher than those with high expression of SF3B1(P＜0.05). After silencing SF3B1, the apoptosis of A549 cells was significantly increased but the proliferation and invasion were significantly decreased. The silence of SF3B1 suppressed the expression of Ras, Raf and p-ERK in A549 cells. Conclusions SF3B1 is highly expressed in NSCLC. Silencing SF3B1 can promote lung cancer cell apoptosis, inhibit cell proliferation and invasion.

Key words: non-small cell lung cancer, splicing factor 3B subunit 1, Ras, Raf, ERK

中图分类号:

R392.2

张小婉, 康霞, 姚小英, 谢芳, 李莹. 沉默SF3B1促进人肺癌细胞系A549凋亡并抑制其增殖及侵袭[J]. 基础医学与临床, 2023, 43(8): 1265-1270.

ZHANG Xiaowan, KANG Xia, YAO Xiaoying, XIE Fang, LI Ying. Silencing SF3B1 promotes apoptosis and inhibits proliferation and invasion of human lung cancer cell line A549[J]. Basic & Clinical Medicine, 2023, 43(8): 1265-1270.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2023.08.1265

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2023/V43/I8/1265

参考文献

[1]卫群芳,朱丽媛,韩为,等.胶质瘤中PTB调控长非编码RNA选择性剪接的筛选[J].基础医学与临床,2018,38:787-792.
[2]Raquel VN, Tarin M, Canbezdi C, et al. Glycolysis dependency as a hallmark of SF3B1-mutated cells[J]. Cancers (Basel), 2022, 14: 2113.doi: 10.3390/cancers14092113.
[3]Yang T, Wang L, Zhang Y. Letter to the editor regarding the article “prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: a meta-analysis”[J]. Crit Rev Oncol Hematol, 2021, 162:103295.doi: 10.1016/j.critrevonc.2021.103295.
[4]Lieu YK, Liu Z, Ali AM, et al. SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes[J]. Proc Natl Acad Sci U S A, 2022, 119: e2111703119.doi: 10.1073/pnas.2111703119.
[5]Popli P, Richters MM, Chadchan SB, et al. Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation[J]. Cell Death Dis, 2020, 11: 842.doi: 10.1038/s41419-020-03055-y.
[6]Yang JY, Huo YM, Yang MW, et al. SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis[J]. Mol Oncol, 2021, 15: 3076-3090.
[7]Fuentes AC, Pérez JM, García ME, et al. SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/β-catenin pathways imbalances[J]. J Exp Clin Cancer Res, 2022, 41: 39. doi: 10.1186/s13046-022-02241-4.
[8]Lopez JL, Rio MD, Fernandez H, et al. Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma[J]. Cancer Letters, 2020, 496:72-93.
[9]Zhang QJ, Di CX, Yan JF, et al. Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells[J]. Artif Cells Nanomed Biotechnol, 2019, 47:1273-1280.
[10]Vacas JM, Aguayo VH, Gómez E, et al. Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer[J]. Transl Res, 2019, 212:89-103.
[11]Ling Z, Xiaojuan Z, Haitao, et al. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing[J]. Breast cancer, 2020, 27:464-476.
[12]Wang YH, Xu H, Lu ZY, et al. Pseudo-Ginsenoside Rh2 induces A549 cells apoptosis via the Ras/Raf/ERK/p53 pathway[J]. Exp Ther Med, 2018, 15: 4916-4924.

[1]	宋婉晴, 李俊发, 崔旭. Herkinorin预处理减轻缺血性卒中模型大鼠脑损伤[J]. 基础医学与临床, 2023, 43(3): 456-461.
[2]	孙秋菊, 焦晓璐, 于华惠, 李凡, 吕倩雯, 王钰, 秦彦文. 血管生成素样蛋白8促进大鼠主动脉血管平滑肌细胞表型转化[J]. 基础医学与临床, 2022, 42(5): 745-751.
[3]	陈勇, 庞红利, 许远征, 毛珊珊, 洪道先. 氯胺酮减轻大鼠脊髓缺血/再灌注损伤[J]. 基础医学与临床, 2022, 42(4): 622-627.
[4]	何邵波, 罗甫花, 蒋传命, 刘选梅. 红景天苷负向调控TACC2表达抑制NSCLC细胞增殖及上皮间充质转化[J]. 基础医学与临床, 2022, 42(11): 1681-1689.
[5]	张瑜, 高建洲, 韩韶. 呋塞米对脑出血模型大鼠PERK/eIF2α/CHOP通路及继发性脑损伤的影响[J]. 基础医学与临床, 2022, 42(1): 100-105.
[6]	韦碧薇, 龚雅慧, 苏州, 杨慧莹, 覃蒙斌, 梁志海. miR-125b参与TRAF6影响的人胰腺导管上皮屏障作用[J]. 基础医学与临床, 2021, 41(9): 1272-1276.
[7]	姜学东, 李文雅. Erastin诱导人非小细胞肺癌细胞系A549凋亡[J]. 基础医学与临床, 2021, 41(9): 1313-1317.
[8]	万雪琼, 陈佳, 何超, 叶星明. 花姜酮通过上调FBXW7表达抑制人非小细胞肺癌细胞系A549增殖、迁移和侵袭[J]. 基础医学与临床, 2021, 41(8): 1163-1168.
[9]	刘细帮, 朱林芝, 焦德敏, 唐夏莉, 陈君, 胡旭钢, 陈清勇. 安罗替尼联合氯喹促进人非小细胞肺癌细胞系H1299凋亡[J]. 基础医学与临床, 2021, 41(7): 1018-1023.
[10]	任孟先, 梁伟, 刘艳. 塞来昔布联合IMRT对老年中晚期非小细胞肺癌患者免疫功能和血清肿瘤标志物的影响[J]. 基础医学与临床, 2021, 41(6): 890-894.
[11]	韩燕, 官丙奇, 周刚, 马菲. 基于DWI的对消岩汤联合GC化学药物治疗晚期非小细胞肺癌疗效的预测价值[J]. 基础医学与临床, 2021, 41(5): 661-666.
[12]	赵晓龙, 代晓燕, 毛成毅, 肖华亮, 王东, 戴楠. 非小细胞肺癌患者血浆外泌体APE1的表达与铂类化疗敏感性相关[J]. 基础医学与临床, 2021, 41(2): 165-170.
[13]	李少儒, 秦海霞, 刘珊珊, 侯瑞杰. miR-493-5p抑制人卵巢癌细胞系SKOV3增殖和迁移[J]. 基础医学与临床, 2021, 41(12): 1749-1755.
[14]	李清平, 刘会群, 蔡萼. 黄芪多糖抑制多发性骨髓瘤细胞系U266增殖、迁移和侵袭[J]. 基础医学与临床, 2020, 40(8): 1083-1089.
[15]	胡耕, 刘枭, 舒鹏程, 彭小忠. 突触黏附分子NECL4对大脑皮质Ca²⁺-CaMKII-CDC42信号通路的影响[J]. 基础医学与临床, 2020, 40(7): 929-933.

沉默SF3B1促进人肺癌细胞系A549凋亡并抑制其增殖及侵袭

Silencing SF3B1 promotes apoptosis and inhibits proliferation and invasion of human lung cancer cell line A549

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价